Why do intestinal epithelial cells express MHC class II?

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Intestinal epithelial cells (IECs) form a barrier between the gut lumen and the immune system.
• IECs possess antigen processing and presentation machinery, suggesting a role as non-conventional antigen-presenting cells.
• Major histocompatibility complex (MHC) class II expression in IECs is regulated by CIITA and IFN-γ, and its role in immune responses is controversial.

Purpose of the Study:

• To investigate the multifaceted consequences of MHC class II antigen presentation by IECs.
• To clarify whether IECs activate effector T cells or regulatory T cells.
• To explore the impact of IEC-derived exosomes and MHC class II expression on intestinal stem cells.

Main Methods:

• Analysis of MHC class II expression in IECs under various conditions.
• Investigating the effects of IEC antigen presentation on T cell subsets (Teff and Treg).
• Studying the role of MHC class II-positive exosomes released by IECs.
• Examining MHC class II expression in intestinal stem cells.

Main Results:

• Conflicting findings exist regarding the immune-enhancing or immunosuppressive roles of IECs and their exosomes.
• IEC MHC class II expression is upregulated during inflammation, potentially activating effector CD4+ T cells.
• Antigen presentation by IECs may also promote regulatory T cell activation, suggesting a suppressive role.
• MHC class II expression by intestinal stem cells may influence epithelial renewal.

Conclusions:

• IECs play a complex role in intestinal immunity, with antigen presentation having diverse outcomes.
• Further research is needed to fully understand the consequences of IEC MHC class II antigen presentation.
• Modulating IEC MHC class II pathways could offer therapeutic strategies for balancing immunity and tolerance in the gut.